R. Gunasegaram et al., EXPRESSION OF 3-BETA-HYDROXYSTEROID DEHYDROGENASE-5,4-EN ISOMERASE ACTIVITY BY INFILTRATING DUCTAL HUMAN BREAST-CARCINOMA IN-VITRO, Breast cancer research and treatment, 50(2), 1998, pp. 117-123
In order to determine whether human mammary tumors could contribute to
progesterone synthesis from pregnenolone in breast cancer patients, h
omogenates of infiltrating ductal primary breast tumors at different s
tages of malignancy (Stages II and III) obtained from pre- and post-me
nopausal patients (n = 7, age 37-66 years) were incubated with [7n-H-3
]pregnenolone as substrate. Controls were heated homogenates instead o
f fresh homogenates. With the use of reverse-isotope dilution analysis
, [H-3]progesterone was isolated and characterized. No such metabolite
was evident in the control incubations of heat-denatured enzymes. The
extent of enzymic conversion varied from 0.02 to 4.0%. The results re
veal that activity of 3 beta-hydroxysteroid dehydrogenase-5,4-en isome
rase that metabolizes pregnenolone to progesterone can be identified w
ith the viable homogenates. It is suggested that there exists a potent
ial for substantial progesterone synthesis in vivo. This conversion ma
y be of considerable clinical, therapeutic, and pathophysiological sig
nificance in the patient with breast cancer. The biological impact of
this conversion should be a high priority research objective.